Mitsubishi UFJ Trust & Banking
AZN icon

Mitsubishi UFJ Trust & Banking’s AstraZeneca AZN Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
100,747
+17,508
+21% +$3.29M 0.04% 367
2026
Q1 		$16.1M Buy
+83,239
New +$16M 0.04% 376

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's AZN Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking increased its AstraZeneca (AZN) stake by 21% in Q2 2026, buying an estimated $3.29M and bringing the position to 100,747 shares worth $18.7M. The position accounts for 0.04% of the portfolio, ranked #367.

Mitsubishi UFJ Trust & Banking first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 100,747 shares of AstraZeneca worth $18.7M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking bought 17,508 AstraZeneca shares in Q2 2026, an estimated $3.29M.
  • AstraZeneca made up 0.04% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #367 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.